OLVIG
AXNX

Oliver Lagore Vanvalin Investment Group’s Axonics, Inc. Common Stock AXNX Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-51
Closed -$4K – 782
2022
Q3 		$4K Buy
+51
New +$3.52K ﹤0.01% 479

Other funds holding AXNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's AXNX Position: Q4 2022 in Review

Oliver Lagore Vanvalin Investment Group sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2022, closing a stake of 51 shares — an estimated $4K sold.

Oliver Lagore Vanvalin Investment Group first reported a position in AXNX in Q3 2022 and held it in 1 quarter. The position peaked at $4K in Q3 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q4 2022.

  • Oliver Lagore Vanvalin Investment Group reported no remaining Axonics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Oliver Lagore Vanvalin Investment Group sold 51 Axonics, Inc. Common Stock shares in Q4 2022, an estimated $4K.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Axonics, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Oliver Lagore Vanvalin Investment Group's Axonics, Inc. Common Stock position peaked at $4K in Q3 2022.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2022.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q4 2022, filed 2 Mar 2023.